Biotechnology

Filter

Current filters:

None

Popular Filters

2101 to 2125 of 2291 results

Dendreon upbeat on Provenge sales

08-01-2012

US biotech firm Dendreon (Nasdaq: DNDN) pleased investors last week when it reported that revenue of…

BiotechnologyDendreonFinancialMarkets & MarketingOncologyProvenge

Drugmakers taking steps to improve R&D productivity, says Tufts CSDD

08-01-2012

Even though pharmaceutical companies are pursuing innovative approaches to increase the pace and reduce…

BiotechnologyPharmaceuticalResearch

Bionomics in $345 million CNS deal with Ironwood

06-01-2012

Australian biotech firm Bionomics (ASX: BNO) entered into a collaboration, research and licensing agreement…

BionomicsBiotechnologyIronwood PharmaceuticalsLicensingNeurologicalPharmaceuticalResearch

Smith & Nephew to spin-out biologics and clinical therapies unit

05-01-2012

Texas, USA-based venture capital firm Essex Woodlands has entered into a strategic partnership with the…

BiotechnologyBioventusMergers & AcquisitionsSmith & Nephew

Isis Pharma could earn $299 million from Biogen Idec deal

05-01-2012

US biotech firm Biogen Idec (Nasdaq: BIIB) has entered into an exclusive, worldwide option and collaboration…

Biogen IdecBiotechnologyIsis PharmaceuticalsLicensingRare diseasesResearch

Many NIH-funded clinical trials go unpublished

04-01-2012

In a study that investigates the challenges of disseminating clinical research findings in peer-reviewed…

BiotechnologyPharmaceuticalResearch

Phylogica signs deal with Johnson & Johnson unit

04-01-2012

Australian peptide drug discovery company Phylogica (ASX: PYC) has entered into a collaboration and option…

BiotechnologyFinancialJanssen BiotechJohnson & JohnsonLicensingPharmaceuticalPhylogica

Biotech predictions for 2012 from sector specialist Steven Burrill

03-01-2012

As 2011 drew to a close, Steven Burrill, chief executive of global life sciences financial services firm…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalRegulation

Baxter taps Momenta expertise on biosimilars

28-12-2011

In another move to capitalize on the anticipated flood of biosimilars coming to the market, as blockbuster…

Baxter InternationalBiotechnologyGenericsLicensingMomenta PharmaceuticalsResearch

Exelixis and Sanofi terminate $1 billion cancer deal

23-12-2011

US biotechnology firm Exelixis (Nasdaq: EXEL) says its oncology deal with French drug Major Sanofi (Euronext:…

BiotechnologyExelixisLicensingOncologyPharmaceuticalResearchSanofi

New EMA measures to facilitate conduct of ENCePP studies

22-12-2011

The European Medicines Agency and the European Network of Centers for Pharmacoepidemiology and Pharmacovigilance…

BiotechnologyEuropePharmaceuticalRegulationResearch

EU patent a step nearer

20-12-2011

The European Union came a step closer to getting a single patent system on Tuesday, when a deal struck…

BiotechnologyEuropePatentsPharmaceutical

Amgen in cancer biosimilars deal with Watson

20-12-2011

A collaboration has been entered into by Amgen (Nasdaq: AMGN), the world’s largest independent biotech…

AmgenBiotechnologyGenericsGlobalLicensingMarkets & MarketingOncologyWatson Pharmaceuticals

Plant molecular farming: a new Biotech Wave

19-12-2011

Currently, the two approved methods of biopharmaceuticals manufacturing widely used in Europe are mammalian…

BASFBayerBiotechnologyPharmaceuticalResearch

Gilead filing of Truvada for PrEP looks contentious

19-12-2011

US biotech firm Gilead Sciences’ (Nasdaq: GILD) decision last week to submit a supplemental New…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalRegulationTruvada

Musical chairs at Amgen and Roche

19-12-2011

USA-based Amgen (Nasdaq: AMGN), the world’s largest independent biotech company, says that Kevin…

AmgenBiotechnologyManagementPharmaceuticalRoche

Germany’s IQWIG negative on InterMune’s Esbriet

18-12-2011

US biotech firm InterMune (Nasdaq: ITMN) says that Germany’s private Institute for Quality and Efficiency…

BiotechnologyEsbrietEuropeInterMuneRare diseasesRegulationRespiratory and Pulmonary

European Medicines Agency’s 2012 work program and budget

18-12-2011

The European Medicines Agency’s Management Board, at its meeting on 15 December 15, adopted the…

BiotechnologyEuropeFinancialGenericsPharmaceuticalRegulationResearch

Where to now for UK Life Sciences?

16-12-2011

The 2012 UK Life Science Industry Leaders Survey* highlights a concern that the UK is losing its position…

BiotechnologyEuropeFinancialPharmaceuticalPricingRegulationResearch

BioSante female libido drug flops in Ph III studies

16-12-2011

its two pivotal Phase III LibiGel (testosterone gel) efficacy trials, joining the list of failures in…

BioSante PharmaceuticalsBiotechnologyLibiGelResearchWomen's Health

2101 to 2125 of 2291 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top